Protein Engineering Market to reach USD 7.39 billion by 2032 at a CAGR of 14.72%

Robust growth in the protein engineering market has been driven by the surging demand for customized therapeutic solutions and advanced diagnostic tools. The core driver for this growth largely lies in the advancement of biotechnological innovations that can modify proteins to enhance their functionality and stability. One of the major drivers of this growth is the increasing need for personalized medicine, and more biopharmaceuticals, including monoclonal antibodies, vaccines, and enzymes-based therapies. This technology helps in solving challenging healthcare issues that are driving this industry\'s demand for engineered proteins for health, agricultural, and industrial use. Yet, the market is also supported by growing investments in biotechnology research, accelerating the discovery and development of novel therapeutic proteins and diagnostics.